TrialAnnals of surgical oncology2025

Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Primary Tumor Location in the Randomized, Double-Blind, Phase III KEYNOTE-716 Trial.

Charles H Yoon et al.PubMed ↗Publisher ↗

No numbers read from the abstract.